Hydrogels for delivery of therapeutic compounds

US10835609B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10835609-B2
Application numberUS-201815906881-A
CountryUS
Kind codeB2
Filing dateFeb 27, 2018
Priority dateJan 14, 2015
Publication dateNov 17, 2020
Grant dateNov 17, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

In some aspects, methacrylate co-polymers crosslinked with an enzymatically cleavable peptide linker are provided and may be used for the oral delivery of a therapeutic. The peptide linker may be cleavable by an enzyme in the small intestine and may allow for the delivery of a therapeutic protein or nucleic acid to the small intestine. Also provided are methods of using the polymers for the treatment of a disease.

First claim

Opening claim text (preview).

What is claimed is: 1. A method for loading a nucleic acid into a copolymer, comprising: (i) incubating a copolymer comprising an acrylic acid, an acrylate monomer, or methacrylic acid in a loading solution comprising the nucleic acid: and subsequently (ii) crosslinking the copolymer with a crosslinker; wherein the crosslinker comprises GRRRGK (SEQ ID NO: 1). 2. The method of claim 1 , wherein the crosslinker is an enzymatically cleavable peptide crosslinker. 3. The method of claim 2 , wherein the copolymer comprises methacrylic acid and N-vinylpyrrolidone. 4. The method of claim 1 , wherein the nucleic acid is a siRNA, an miRNA, or an shRNA. 5. The method of claim 1 , wherein the copolymer is a P(MAA-co-NVP) copolymer; and wherein the crosslinker is an enzymatically cleavable peptide linker, wherein the peptide linker is 6-25 amino acid residues in length and contains at least one lysine amino acid. 6. The method of claim 2 , wherein the peptide crosslinker is 6-20 amino acid residues in length. 7. The method of claim 1 , wherein the hydrogel polymer comprises the structure: 8. The method of claim 2 , wherein the polymer is crosslinked with the peptide through the use of a coupling reagent. 9. The method of claim 8 , wherein the coupling reagent is a carbodiimide. 10. The method of claim 2 , wherein the polymer is crosslinked with the peptide via an EDC-NHS reaction. 11. A method for loading a nucleic acid into a copolymer, comprising: (i) incubating a copolymer comprising an acrylic acid, an acrylate monomer, or methacrylic acid in a loading solution comprising the nucleic acid; and subsequently (ii) crosslinking the copolymer with a crosslinker; wherein the crosslinker comprises the structure: 12. The method of claim 11 , wherein the crosslinker is an enzymatically cleavable peptide crosslinker. 13. The method of claim 12 , wherein the copolymer comprises methacrylic acid and N-vinylpyrrolidone. 14. The method of claim 11 , wherein the nucleic acid is a siRNA, an miRNA, or an shRNA. 15. The method of claim 11 , wherein the copolymer is a P(MAA-co-NVP) copolymer; and wherein the crosslinker is an enzymatically cleavable peptide linker, wherein the peptide linker is 6-25 amino acid residues in length and contains at least one lysine amino acid. 16. The method of claim 12 , wherein the peptide crosslinker is 6-20 amino acid residues in length. 17. The method of claim 11 , wherein the copolymer comprises the structure: 18. The method of claim 12 , wherein the copolymer is crosslinked with the peptide through the use of a coupling reagent. 19. The method of claim 18 , wherein the coupling reagent is a carbodiimide. 20. The method of claim 12 , wherein the copolymer is crosslinked with the peptide via an EDC-NHS reaction.

Assignees

Inventors

Classifications

  • Peptides having 5 to 11 amino acids {(A61K38/043 - A61K38/046 take precedence)} · CPC title

  • Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants C12N15/8218)} · CPC title

  • obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates · CPC title

  • Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof {(enzyme inhibitors A61K38/005)} · CPC title

  • General methods applicable to biologically active non-coding nucleic acids · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10835609B2 cover?
In some aspects, methacrylate co-polymers crosslinked with an enzymatically cleavable peptide linker are provided and may be used for the oral delivery of a therapeutic. The peptide linker may be cleavable by an enzyme in the small intestine and may allow for the delivery of a therapeutic protein or nucleic acid to the small intestine. Also provided are methods of using the polymers for the tre…
Who is the assignee on this patent?
Univ Texas
What technology area does this patent fall under?
Primary CPC classification A61K47/32. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Nov 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).